Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Catalyst Pharm Inc (CPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 348,840
  • Shares Outstanding, K 102,600
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,410 K
  • 36-Month Beta 1.52
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.57

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.61 +24.90%
on 04/26/18
3.51 -6.99%
on 05/23/18
+0.62 (+23.48%)
since 04/25/18
3-Month
2.18 +49.54%
on 04/04/18
3.51 -6.99%
on 05/23/18
+0.03 (+0.93%)
since 02/23/18
52-Week
2.09 +55.98%
on 07/18/17
4.51 -27.72%
on 12/01/17
+1.09 (+50.23%)
since 05/25/17

Most Recent Stories

More News
Catalyst (CPRX) Posts In-Line Q1 Loss, Pipeline Progresses

Catalyst reported in-line loss in Q1. The company resubmitted a new drug application for its lead candidate Firdapse and expects FDA to accept the NDA in Q2.

LGND : 189.25 (-0.09%)
CATB : 1.59 (-1.24%)
ENTA : 96.46 (-1.25%)
CPRX : 3.26 (-4.12%)
Catalyst Pharmaceuticals Announces First Quarter 2018 Financial Results and Provides Corporate Update

Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological...

CPRX : 3.26 (-4.12%)
What's in Store for Catalyst (CPRX) This Earnings Season?

Catalyst (CPRX) is expected to report first-quarter 2018 results on May 9, after the market closesa and investor's focus will be on pipeline and regulatory updates during the earnings call.

CELG : 78.63 (-1.14%)
ADVM : 6.15 (unch)
EBS : 49.99 (-1.23%)
CPRX : 3.26 (-4.12%)
Catalyst Pharmaceuticals to Hold First Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, May 10th, 2018

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.26 (-4.12%)
Catalyst Pharmaceuticals Introduces New Corporate Website

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.26 (-4.12%)
Catalyst Enrolls First Patient in Phase III Firdapse Study

Catalyst (CPRX) enrolls the first patient in its phase III clinical trial (MSK-002) to evaluate the efficacy and safety of Firdapse in patients with MuSK antibody positive Myasthenia Gravis.

PTGX : 6.66 (+0.76%)
LGND : 189.25 (-0.09%)
BMRN : 92.49 (+4.77%)
CPRX : 3.26 (-4.12%)
Report: Developing Opportunities within Clean Energy Fuels, Catalyst Pharmaceuticals, Qorvo, Brunswick, DCT Industrial Trust, and Radius Health -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Clean Energy Fuels Corp. (NASDAQ:CLNE),...

BC : 62.81 (+0.66%)
DCT : 65.04 (-0.14%)
RDUS : 29.17 (+1.64%)
CPRX : 3.26 (-4.12%)
QRVO : 81.49 (+0.32%)
CLNE : 2.63 (-4.01%)
Catalyst Pharmaceuticals Announces Enrollment of First Patient in Phase 3 Trial of Firdapse(R) in MuSK Antibody Positive Myasthenia Gravis

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...

CPRX : 3.26 (-4.12%)
Catalyst Pharmaceuticals (CPRX) Down 7.4% Since Earnings Report: Can It Rebound?

Catalyst Pharmaceuticals (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CPRX : 3.26 (-4.12%)
Catalyst (CPRX) Up on New Drug Application for Firdapse

Catalyst (CPRX) new drug application for its lead pipeline candidate keeps it on a growth trajectory.

LGND : 189.25 (-0.09%)
BMRN : 92.49 (+4.77%)
REGN : 293.74 (-0.30%)
CPRX : 3.26 (-4.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade CPRX with:

Business Summary

CATALYST PHARMACEUTICAL PARTNERS, INC. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for...

See More

Key Turning Points

2nd Resistance Point 3.50
1st Resistance Point 3.38
Last Price 3.26
1st Support Level 3.18
2nd Support Level 3.11

See More

52-Week High 4.51
Fibonacci 61.8% 3.59
Fibonacci 50% 3.30
Last Price 3.26
Fibonacci 38.2% 3.01
52-Week Low 2.09

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar